Category: isoxazole

Some dimethyldiisoxazolone derivatives was written by Caramella, Pierluigi;Gruenanger, Paolo. And the article was included in Chimica e l’Industria (Milan, Italy) in 1967.Related Products of 19668-85-0 This article mentions the following:

3-Methyl-4-(3-methylisoxazol-5-yl)-3-isoxazolin-5-one [I (R = H)] (II) is prepared and used in the preparation of III and IV. II, m. 169-70° (decomposition), is prepared according to 3 known methods. A solution is prepared from 9.0 g. II and 38 ml. POCl3, 7.0 ml. Et3N is slowly added, and the mixture is refluxed 90 min. to give 64% III (X = Cl) (V), m. 89-90° (hexane). A mixture of 1.0 g. V in C6H6 is treated with 3.0 ml. morpholine and the mixture is kept 2 days to give 96% III (X = morpholino), m. 89-90° (cyclohexane); N.M.R. data are given. A solution of 1.0 g. V in 30 ml. 0.24M KOH (MeOH) is agitated 3 hrs. to give 72% III (X = MeO) (VI), m. 73-4° (ligroine). Similarly prepared is III (X = EtO), m. 89-90° (hexane). VI (0.5 g.) in 50 ml. MeOH is hydrogenated in the presence of 0.1 g. 5% Pd/C to give 90% Me 2-(3-methylisoxazol-5-yl)-3-aminocrotonate (VII), m. 91-2° (C6H6-hexane). Similarly prepared is IV [R = C(CO2Et):C(NH2)Me] (VIII), m. 106-7° (C6H6-hexane); acetyl derivative m. 84-5° (cyclohexane). A mixture of 2.55 millimoles VII (or VIII) and 15 ml. 1:1 H2SO4 is refluxed 1 hr. to give IV (R = CH2CO2H), m. 106-7° (C6H6). A solution of 120 mg. VII and 50 mg. HONH2.HCl in 20 ml. EtOH is refluxed 2 hrs. to give 82% II, m. 167-8° (decomposition) (water). A solution of 0.5 g. VII and 0.22 g. HONHMe.HCl in 20 ml. EtOH is refluxed 2 hrs. to give 71% I (R = Me) (VIII), m. 163-4° (water). II (10 millimoles) is treated with excess CH2N2 to give a mixture of VI and VIII. Similarly prepared is a mixture of III (X = EtO) (IX) and I (R = Et) (X), m. 97-8° (iso-Pr2O). A mixture of 4.5 millimoles II in 10 ml. water is neutralized with 0.5N NaOH, 0.1N AgNO3 is added, and the mixture is heated with MeI in C6H6 to give a mixture of VI and VIII. Similarly prepared is a mixture of IX and X. Ir and uv data are given. In the experiment, the researchers used many compounds, for example, 3-Methylisoxazole-5-acetic Acid (cas: 19668-85-0Related Products of 19668-85-0).

3-Methylisoxazole-5-acetic Acid (cas: 19668-85-0) belongs to isoxazole derivatives. Isoxazoles present in various natural products and synthetic compounds of biological importance like antibacterial, antagonists, antiinflammatory, analgesics, and also show the applications in functional materials. The most common methods for N–O bond cleavage in isoxazoles are hydrogenation with palladium or platinum catalysts or with Raney Ni. Recent developments have shown that Mo(CO)6 efficiently cleaves the N–O bond in isoxazoles.Related Products of 19668-85-0

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

HIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant Variants was written by Altman, Michael D.;Ali, Akbar;Reddy, G. S. Kiran Kumar;Nalam, Madhavi N. L.;Anjum, Saima Ghafoor;Cao, Hong;Chellappan, Sripriya;Kairys, Visvaldas;Fernandes, Miguel X.;Gilson, Michael K.;Schiffer, Celia A.;Rana, Tariq M.;Tidor, Bruce. And the article was included in Journal of the American Chemical Society in 2008.HPLC of Formula: 321309-26-6 This article mentions the following:

The acquisition of drug-resistant mutations by infectious pathogens remains a pressing health concern, and the development of strategies to combat this threat is a priority. Here the authors have applied a general strategy, inverse design using the substrate envelope, to develop inhibitors of HIV-1 protease. Structure-based computation was used to design inhibitors predicted to stay within a consensus substrate volume in the binding site. Two rounds of design, synthesis, exptl. testing, and structural anal. were carried out, resulting in a total of 51 compounds Improvements in design methodol. led to a roughly 1000-fold affinity enhancement to a wild-type protease for the best binders, from a K_i of 30-50 nM in round one to below 100 pM in round two. Crystal structures of a subset of complexes revealed a binding mode similar to each design that respected the substrate envelope in nearly all cases. All four best binders from round one exhibited broad specificity against a clin. relevant panel of drug-resistant HIV-1 protease variants, losing no more than 6-13-fold affinity relative to wild type. Testing a subset of second-round compounds against the panel of resistant variants revealed three classes of inhibitors: robust binders (maximum affinity loss of 14-16-fold), moderate binders (35-80-fold), and susceptible binders (greater than 100-fold). Although for especially high-affinity inhibitors addnl. factors may also be important, overall, these results suggest that designing inhibitors using the substrate envelope may be a useful strategy in the development of therapeutics with low susceptibility to resistance. In the experiment, the researchers used many compounds, for example, 5-Methyl-4-isoxazolesulfonyl chloride (cas: 321309-26-6HPLC of Formula: 321309-26-6).

5-Methyl-4-isoxazolesulfonyl chloride (cas: 321309-26-6) belongs to isoxazole derivatives. An isoxazolyl group is found in many beta-lactamase-resistant antibiotics, such as cloxacillin, dicloxacillin and flucloxacillin. As with isoxazolines, isoxazoles may be cleaved using low-valent titanium obtained from the Kulinkovich reaction.This procedure affords enaminoketones from 2,4-substituted isoxazoles.HPLC of Formula: 321309-26-6

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Phosphate binder for dialysis patients was written by Becker, Conny;Gensthaler, Brigitte M.;Grafe, Kerstin A.;Morck, Hartmut. And the article was included in Pharmazeutische Zeitung in 2007.Application In Synthesis of Sodium (4-chloro-3-methylisoxazol-5-yl)((2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)thiophen-3-yl)sulfonyl)amide This article mentions the following:

Characteristics, pharmacodynamics, and pharmacokinetics are discussed of a new Ca-free phosphate binder, lanthanum carbonate (Fosrenol), for dialysis patients with terminal nephrotic insufficiency to avoid hyperphosphatemia. 4 New drugs are characterized: oxytocin analog carbetocin (Pabal), Tyr kinase inhibitor dasatinib (Sprycel), cyclooxygenase (COX)-2 inhibitor lumiracoxib (Prexige), and endothelin-A-receptor inhibitor sitaxentan (Thelin). In the experiment, the researchers used many compounds, for example, Sodium (4-chloro-3-methylisoxazol-5-yl)((2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)thiophen-3-yl)sulfonyl)amide (cas: 210421-74-2Application In Synthesis of Sodium (4-chloro-3-methylisoxazol-5-yl)((2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)thiophen-3-yl)sulfonyl)amide).

Sodium (4-chloro-3-methylisoxazol-5-yl)((2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)thiophen-3-yl)sulfonyl)amide (cas: 210421-74-2) belongs to isoxazole derivatives. An isoxazolyl group is found in many beta-lactamase-resistant antibiotics, such as cloxacillin, dicloxacillin and flucloxacillin. As with isoxazolines, isoxazoles may be cleaved using low-valent titanium obtained from the Kulinkovich reaction.This procedure affords enaminoketones from 2,4-substituted isoxazoles.Application In Synthesis of Sodium (4-chloro-3-methylisoxazol-5-yl)((2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)thiophen-3-yl)sulfonyl)amide

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

ACE2:S1 RBD interaction-targeted peptides and small molecules as potential COVID-19 therapeutics was written by Chitsike, Lennox;Krstenansky, John;Duerksen-Hughes, Penelope J.. And the article was included in Advances in Pharmacological and Pharmaceutical Sciences in 2021.Reference of 883944-52-3 This article mentions the following:

The COVID-19 pandemic that began in late 2019 continues with new challenges arising due to antigenic drift as well as individuals who cannot or choose not to take the vaccine. There is therefore an urgent need for addnl. therapies that complement vaccines and approved therapies such as antibodies in the fight to end or slow down the pandemic. SARS-CoV-2 initiates invasion of the human target cell through direct contact between the receptor-binding domain of its Spike protein and its cellular receptor, angiotensin-converting enzyme-2 (ACE2). The ACE2 and S1 RBD interaction, therefore, represents an attractive therapeutic intervention to prevent viral entry and spread. In this study, we developed a proximity-based AlphaScreen assay that can be utilized to quickly and efficiently screen for inhibitors that perturb the ACE2:S1 RBD interaction. We then designed several peptides candidates from motifs in ACE2 and S1 RBD that play critical roles in the interaction, with and without modifications to the native sequences. We also assessed the possibility of reprofiling of candidate small mols. that previously have been shown to interfere with the viral entry of SARS-CoV. Using our optimized AlphaScreen assay, we evaluated the activity and specificity of these peptides and small mols. in inhibiting the binding of ACE2:S1 RBD. This screen identified cepharanthine as a promising candidate for development as a SARS-CoV-2 entry inhibitor. In the experiment, the researchers used many compounds, for example, N-(4-(4-Methylpiperazin-1-yl)benzyl)isoxazole-5-carboxamide (cas: 883944-52-3Reference of 883944-52-3).

N-(4-(4-Methylpiperazin-1-yl)benzyl)isoxazole-5-carboxamide (cas: 883944-52-3) belongs to isoxazole derivatives.Synthetically, isoxazoles serve as valuable precursors for the construction of diverse molecules, including many natural products. Isoxazole can be synthesised via a variety of methods. Examples include via the reaction of hydroxylamine with 1,3-diketones or derivatives of propiolic acid.Reference of 883944-52-3

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone was written by Taurines, R.;Fekete, S.;Preuss-Wiedenhoff, A.;Warnke, A.;Wewetzer, C.;Plener, P.;Burger, R.;Gerlach, M.;Romanos, M.;Egberts, K. M.. And the article was included in Journal of Neural Transmission in 2022.Recommanded Product: 144598-75-4 This article mentions the following:

Risperidone is commonly used to treat different psychiatric disorders worldwide. Knowledge on dose-concentration relationships of risperidone treatment in children and adolescents with schizophrenia or other psychotic disorders is, however, scarce and no age-specific therapeutic ranges have been established yet. Multicenter data of a therapeutic drug monitoring service were analyzed to evaluate the relationship between risperidone dose and serum concentration of the active moiety (risperidone (RIS) plus its main metabolite 9-hydroxyrisperidone (9-OH-RIS)) in children and adolescents with psychotic disorders. Patient characteristics, doses, serum concentrations and therapeutic outcomes were assessed by standardized measures. The study also aimed to evaluate whether the therapeutic reference range for adults (20-60 ng/mL) is applicable for minors. In the 64 patients (aged 11-18 years) included, a pos. correlation between daily dose and the active moiety (RIS_am) concentration was found (r_s = 0.49, p = 0.001) with variation in dose explaining 24% (r_s² = 0.240) of the variability in serum concentrations While the RIS_am concentration showed no difference, RIS as well 9-OH-RIS concentrations and the parent to metabolite ratio varied significantly in patients with co-medication of a CYP2D6 inhibitor. Patients with extrapyramidal symptoms (EPS) had on average higher RISam concentrations than patients without (p = 0.05). Considering EPS, the upper threshold of the therapeutic range of RIS_am was determined to be 33 ng/mL. A rough estimation method also indicated a possibly decreased lower limit of the preliminary therapeutic range in minors compared to adults. These preliminary data may contribute to the definition of a therapeutic window in children and adolescents with schizophrenic disorders treated with risperidone. TDM is recommended in this vulnerable population to prevent concentration-related adverse drug reactions. In the experiment, the researchers used many compounds, for example, 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4Recommanded Product: 144598-75-4).

3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4) belongs to isoxazole derivatives. Isoxazoles present in various natural products and synthetic compounds of biological importance like antibacterial, antagonists, antiinflammatory, analgesics, and also show the applications in functional materials. The electrophilic cyclization of various 2-alkynone O-methyl oximes with a wide range of substrates such as ICl, I2, Br2, PhSeBr, etc. provides a variety of 3,4,5-trisubstituted isoxazoles in good to excellent yields.Recommanded Product: 144598-75-4

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein Interface was written by Van Molle, Inge;Thomann, Andreas;Buckley, Dennis L.;So, Ernest C.;Lang, Steffen;Crews, Craig M.;Ciulli, Alessio. And the article was included in Chemistry & Biology (Oxford, United Kingdom) in 2012.Synthetic Route of C6H7NO3 This article mentions the following:

Fragment screening is widely used to identify attractive starting points for drug design. However, its potential and limitations to assess the tractability of often challenging protein:protein interfaces have been underexplored. Here, we address this question by means of a systematic deconstruction of lead-like inhibitors of the pVHL:HIF-1α interaction into their component fragments. Using biophys. techniques commonly employed for screening, we could only detect binding of fragments that violate the Rule of Three, are more complex than those typically screened against classical druggable targets, and occupy two adjacent binding subsites at the interface rather than just one. Analyses based on ligand and group lipophilicity efficiency of anchored fragments were applied to dissect the individual subsites and probe for binding hot spots. The implications of our findings for targeting protein interfaces by fragment-based approaches are discussed. In the experiment, the researchers used many compounds, for example, 3-Methylisoxazole-5-acetic Acid (cas: 19668-85-0Synthetic Route of C6H7NO3).

3-Methylisoxazole-5-acetic Acid (cas: 19668-85-0) belongs to isoxazole derivatives.Synthetically, isoxazoles serve as valuable precursors for the construction of diverse molecules, including many natural products. Fe(CO)5 efficiently cleaves the N–O bond of fused isoxazolo-1,4-quinones to give the corresponding imines.All the common reducing reagents failed to open the isoxazole ring.Synthetic Route of C6H7NO3

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

The pyrolysis of isoxazole revisited: A new primary product and the pivotal role of the vinylnitrene. A low-temperature matrix isolation and computational study was written by Nunes, Claudio M.;Reva, Igor;Pinho e Melo, Teresa M. V. D.;Fausto, Rui;Solomek, Tomas;Bally, Thomas. And the article was included in Journal of the American Chemical Society in 2011.Quality Control of 5-Methylisoxazole This article mentions the following:

This paper describes the pyrolysis of parent isoxazole and of its 5-Me and 3,5-di-Me derivatives by the high-pressure pulsed pyrolysis method, where activation of the precursor mols. occurs predominantly by collisions with the host gas (Ar in our case), rather than with the walls of the pyrolysis tube, where catalyzed processes may occur. The products were trapped at 15 K in Ar matrixes and were characterized by vibrational spectroscopy. Thereby, hitherto unobserved primary products of pyrolysis of isoxazole and of its 5-Me derivative, 3-hydroxypropenenitrile or 3-hydroxybutenenitrile, resp., were observed E-Z photoisomerization could be induced in the above hydroxynitriles. On pyrolysis of isoxazole, ketenimine and CO were observed as decomposition products, but this process did not occur when the 5-Me derivative was pyrolyzed. Instead, the corresponding ketonitrile was formed. In the case of 3,5-dimethylisoxazole, 2-acetyl-3-methyl-2H-azirine was detected at moderate pyrolysis temperatures, whereas at higher temperatures, 2,5-dimethyloxazole was the only observed rearrangement product (next to products of dissociation). These findings are rationalized on the basis of quantum chem. calculations Thereby it becomes evident that carbonyl-vinylnitrenes play a pivotal role in the observed rearrangements, a role that had not been recognized in previous theor. studies because it had been assumed that vinylnitrenes are closed-shell singlet species, whereas they are in fact open-shell singlet biradicaloids. Thus, the primary processes had to be modeled by the multiconfigurational CASSCF method, followed by single-point MR-CISD calculations The picture that emerges from these calculations is in excellent accord with the exptl. findings; i.e., they explain why some possible products are observed while others are not. In the experiment, the researchers used many compounds, for example, 5-Methylisoxazole (cas: 5765-44-6Quality Control of 5-Methylisoxazole).

5-Methylisoxazole (cas: 5765-44-6) belongs to isoxazole derivatives. Isoxazole are described as inhibitors of acetylcholinesterase (AChE). Isoxazole ligands bind to and inhibit the Sxc- antiporter. Some alternative routes for the synthesis of isoxazoles have also been developed and reported. The 2-benzoyl-2-halo-2H-azirines provide 4-haloisoxazoles in good yields after heating in toluene at reflux temperature.Quality Control of 5-Methylisoxazole

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Comparative study on determination of risperidone and paliperidone in human serum by LC-MS/MS and HPLC was written by Deng, Shunshun;Liang, Guochao;Gao, Yongshuang. And the article was included in Jianyan Yixue Yu Linchuang in 2021.HPLC of Formula: 144598-75-4 This article mentions the following:

Objective: To verify the reliability of liquid chromatog.-mass spectrometry (LC-MS/MS) and high performance liquid chromatog. (HPLC) for the determination of risperidone and paliperidone in human serum, and to analyze the difference between the two methods. Methods: The methods of LC-MS/MS and HPLC for the determination of risperidone and paliperidone in human serum were verified. After passed the test, 60 serum samples of inpatients in the hospital were tested. Paired t-test, Pearson correlation anal., scatter plot and Bland-Altman deviation plot were used to evaluate the correlation and difference of the test results. Results: The methodol. verification of LC-MS/MS method and HPLC method met the requirements, and the detection results were pos. correlated. The difference between the detection results of LC-MS/MS method and HPLC method was statistically significant (P < 0.05). The results of LC-MS/MS detection of risperidone and paliperidone were 1.97 and 1.38 ng/mL higher than the HPLC detection results, resp., and the 95% confidence intervals were (-5.81)-9.74, (-10.28)-11.66, resp. Conclusion: LC-MS/MS method and HPLC method can be used to detect the plasma concentrations of risperidone and paliperidone in human serum at the same time. The detection results are reliable, but the results are different. If patients need long-term monitoring, it is recommended to always use the same method. In the experiment, the researchers used many compounds, for example, 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4HPLC of Formula: 144598-75-4).

3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4) belongs to isoxazole derivatives. Isoxazole are described as inhibitors of acetylcholinesterase (AChE). Isoxazole ligands bind to and inhibit the Sxc- antiporter. The most common methods for N–O bond cleavage in isoxazoles are hydrogenation with palladium or platinum catalysts or with Raney Ni. Recent developments have shown that Mo(CO)6 efficiently cleaves the N–O bond in isoxazoles.HPLC of Formula: 144598-75-4

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Tandem mass spectrometry study of the flash vacuum pyrolysis of some 1,2,4-triazolides was written by Maquestiau, A.;Puk, E.;Flammang, R.. And the article was included in Bulletin des Societes Chimiques Belges in 1987.Product Details of 5765-44-6 This article mentions the following:

A real-time anal. of the flash-vacuum pyrolysis products of 1,2,4-triazolides was performed by tandem mass spectrometry. Thus, 1-acyltriazoles gave 5-alkyloxazoles, in competition with formation of ketenes. This ring formation occurred by a sigmatropic shift of the acyl group from N to C, loss of N, and cyclization of the biradical intermediate. In the experiment, the researchers used many compounds, for example, 5-Methylisoxazole (cas: 5765-44-6Product Details of 5765-44-6).

5-Methylisoxazole (cas: 5765-44-6) belongs to isoxazole derivatives. Isoxazole are described as inhibitors of acetylcholinesterase (AChE). Isoxazole ligands bind to and inhibit the Sxc- antiporter. The electrophilic cyclization of various 2-alkynone O-methyl oximes with a wide range of substrates such as ICl, I2, Br2, PhSeBr, etc. provides a variety of 3,4,5-trisubstituted isoxazoles in good to excellent yields.Product Details of 5765-44-6

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [¹⁸F]DOPA and [¹¹C]raclopride PET study in first-episode psychosis was written by Kim, Seoyoung;Shin, Sang Ho;Santangelo, Barbara;Veronese, Mattia;Kang, Seung Kwan;Lee, Jae Sung;Cheon, Gi Jeong;Lee, Woojoo;Kwon, Jun Soo;Howes, Oliver D.;Kim, Euitae. And the article was included in Molecular Psychiatry in 2021.Quality Control of 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one This article mentions the following:

Although antipsychotic drugs are effective for relieving the psychotic symptoms of first-episode psychosis (FEP), psychotic relapse is common during the course of the illness. While some FEPs remain remitted even without medication, antipsychotic discontinuation is regarded as the most common risk factor for the relapse. Considering the actions of antipsychotic drugs on presynaptic and postsynaptic dopamine dysregulation, this study evaluated possible mechanisms underlying relapse after antipsychotic discontinuation. Twenty five FEPs who were clin. stable and 14 matched healthy controls were enrolled. Striatal dopamine activity was assessed as Kicer value using [¹⁸F]DOPA PET before and 6 wk after antipsychotic discontinuation. The D2/3 receptor availability was measured as BPND using [¹¹C]raclopride PET after antipsychotic discontinuation. Healthy controls also underwent PET scans according to the corresponding schedule of the patients. Patients were monitored for psychotic relapse during 12 wk after antipsychotic discontinuation. 40% of the patients showed psychotic relapse after antipsychotic discontinuation. The change in Kicer value over time significantly differed between relapsed, non-relapsed patients and healthy controls (Week*Group: F = 4.827, df = 2,253.193, p = 0.009). In relapsed patients, a significant correlation was found between baseline striatal Kicer values and time to relapse after antipsychotic discontinuation (R2 = 0.518, p = 0.018). BPND were not significantly different between relapsed, non-relapsed patients and healthy controls (F = 1.402, df = 2,32.000, p = 0.261). These results suggest that dysfunctional dopamine autoregulation might precipitate psychotic relapse after antipsychotic discontinuation in FEP. This finding could be used for developing a strategy for the prevention of psychotic relapse related to antipsychotic discontinuation. In the experiment, the researchers used many compounds, for example, 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4Quality Control of 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one).

3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4) belongs to isoxazole derivatives. Isoxazoles also form the basis for a number of drugs, including the COX-2 inhibitor valdecoxib (Bextra) and a neurotransmitter agonist AMPA. Fe(CO)5 efficiently cleaves the N–O bond of fused isoxazolo-1,4-quinones to give the corresponding imines.All the common reducing reagents failed to open the isoxazole ring.Quality Control of 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem